We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SAN DIEGO — An intravenous formulation of secukinumab ...
Please provide your email address to receive an email when new articles are posted on . In 73% of patients with skin of color, PASI 90 was achieved with secukinumab treatment. Patient-reported ...
The approval was based on data from the phase 3 SUNSHINE and SUNRISE trials, which included 1084 adults with moderate to severe HS. Results showed a significantly greater proportion of patients ...
The Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) injections for treating various inflammatory conditions in adults and, in some cases, children. Cosentyx may treat moderate ...
Compared with patients with psoriatic arthritis (PsA) receiving placebo, those receiving secukinumab demonstrated a significant reduction in bone erosion volume and improvement in partial healing of ...
The Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) injections to treat several inflammatory conditions. Adults and certain children can receive this medication to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results